Arthritis/rheumatic disorders:

Indications for: EUFLEXXA

Osteoarthritis of the knee in patients who have failed nonpharmacologic therapy and analgesics (eg, acetaminophen).

Adult Dosage:

Prior to treatment: remove joint effusion (use separate syringe), if present. Inject 2mL (full syringe contents) intra-articularly in each affected knee weekly for 3 weeks. Use separate syringes for each knee.

Children Dosage:

Not recommended.

EUFLEXXA Contraindications:

Knee joint infection or skin disease at inj site.

EUFLEXXA Warnings/Precautions:

Repeated treatment cycles: not established. Avoid intravascular injection. Avoid strenuous activity within 48hrs after injection. Pregnancy. Nursing mothers.

EUFLEXXA Classification:


EUFLEXXA Interactions:

Avoid disinfectants with quaternary ammonium salts. Concomitant other intra-articular injectables: not recommended.

Adverse Reactions:

Arthralgia, increase blood pressure, inj site pain, local reactions, transient knee inflammation.

How Supplied:

Single-use prefilled syringes (2mL)—1